Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04139434
Title Dose-escalation Study of Oral Administration of LP-108 in Patients With Relapsed or Refractory Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Newave Pharmaceutical Inc
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of Michigan Ann Arbor Michigan 48109 United States Details
University of Cincinnati Cincinnati Ohio 45221 United States Details
Ohio State Comprehensive Cancer Center Columbus Ohio 43210 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Institut Català d'oncologia - ICO Badalona Badalona Barcelona 08916 Spain Details
Hospital San Pedro de Alcántara Cáceres 10003 Spain Details
Instituto de Investigación Sanitaria La Fe Valencia CP 46026 Spain Details
*Shaded cells indicate that there was no data available from for the field